Clinical Trials Browser

Multi-centric Castleman's Disease × Sarcoma × 1 year × Clear all

NCT05907759 2026-03-18

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Phase 2 Recruiting

28 enrolled

LymphoidSarcoma

Multi-centric Castleman's Disease, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, Primary Effusion

NCT00006518 2026-02-25

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Recruiting

1,029 enrolled

LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Lymphoma, Neoplasms, Sarcoma, Kaposi, Virus Diseases, Lymphoma, Primary Effusion

NCT02659930 2026-02-19

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

Phase 1 Active not recruiting

62 enrolled

Sarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05663502 2025-07-17

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Recruiting

200 enrolled

GastrointestinalLymphoidOther hematologic neoplasmSarcoma

Multi-centric Castleman's Disease, Plasmablastic Lymphoma, Anus Neoplasms, Lymphoma, Sarcoma, Kaposi, HIV Infections, Hematologic Neoplasms